T he new "Star Trek" opened recently, presenting the back story (reboot) to the original "Star Trek" television show which ran from 1966-1969. When I was in medical school, the evening of "Star Trek" was a major social event including, dinner, watching the show, then endless dissection of the episode. Bones, the ship doctor rarely entered into our discussion, other than as a character. His little black box scans, and occasional injections seemed too improbable to be relevant. It was only in watching the current film that the reality of Bones' magic became evident. Bones would love cosmetic surgery today. There are so many effective injections (think of all our fillers, and Botox), so much black-box technology (think lasers, ultrasound, and radiofrequency), that he would be right at home.
What once would have passed for magical thinking is now a reality. The proliferation of tools and techniques is amazing. For the past 2 months I have been engaged in the pursuit of trying something new (t~me at least) at least once a week. A lot of these thI~gS were seen and described at the annual AACS meetmg at the beginning of the year. More are gleaned from journals and ads. But most come f~om sources. such as Plastic Surgery Products or Cosmetic Surgery TImes. In trying these products, whether they are a. new suture (Quill) or subcutaneous staple suture device (Insorb), cutting tool (carbon fiber blade,~armon~c scalpel, plasma knife), injectable, laser a~sIsted liposuction, skin laser, acellular dermal matnx, or even a new technique, I try and ask several specific questions:
1. Does this matter? That is, will using this improve the result?
2. Is the difference significant enough to warrant inclusion in my work regularly? 3. Is the use of this cost effective? 4. Is this the best advance available or IS there another (whatever) even better?
As a mature surgeon, I have been lucky to practice in a setting unlike many of my colleagues. Rather than working in a private office setting, I have been in either an academic center or in the Institute for Aesthetic Surgery and Medicine where we have many doctors from different specialties much like the Academy, working together collegially, even when coming from competing practices. Watching the way someone else works, talking about the latest meeting someone else has attended keeps opening new doors in a way that just working alone, reading, and going to meetings occasionally, cannot provide.
This "try something new" project has been fun, but it provides no useful function to the wider field of medicine/surgery. It does not permit the creation of any scientific data, comparative evaluation, or objective research. Yet modem medicine has very demanding standards. Evidence-based practice has become one of the goals of clinical research.
A recent education review by Ridgeway and Guller' provides a thorough discussion of surgical clinical research, study design, and interpretation. The basic clinical surgical paper can be characterized as one of several types: Case report, case series, case controlled, cohort study, meta-analysis or systematic review.
The isolated surgeon can easily generate a case report, or a case series and the AlCS has regularly presented such papers. A case controlled study compares two groups, one possibly a set of historical controls. Case series, case controlled studies and cohort series can be prospective or retrospective in nature. These, too, are within the grasp of the practicing physician but require a rigorous study design, meticulous data collection, and competent statistical analysis, and are therefore much more demanding within the confines of the private practice.
Prospective randomized clinical trials represent the most rigorous study design but are rarely found in plastic or cosmetic surgery. Momei, Becker, Antes, et af reviewed 3 articles from plastic surgery journals published between 1990 and 2005, finding that over time, an increasing percentage of total papers provided some form of controlled clinical trial but still only accounted for less than 4% of the papers published. They did not break down the papers by reconstructive or aesthetic procedure. Virtually all of these clinical trials came from university programs in either Europe or North America.
An alternative study design, utilizing outcomes research offers the opportunity to include patient satisfaction in the equation, certainly a critical parameter in cosmetic surgery.' Ching and his colleagues have further elucidated this approach in a more recent paper," Studies that utilize well defined quality of life measurements are certainly possible within the Academy community.'
Let us just briefly look at the available technology for laser assisted liposuction. To do that, it is nearly impossible to look beyond the incredible hype that this technology has generated. The names alone are quite telling. Parlette and Kaminer" generated a table in their review paper of names, wavelengths and pulse output. They describe SlirnLipo, LipoLite, SmartLipo, SmartLipoMPX, ProLipo and CoolLipo. There is some wavelength overlap, and maximum pulse wattage output variations between the machines but otherwise more significant similarities. And these are just the internal laser liposuction devices. Add to these the external low level laser tools, and the ultrasound internal and external technologies and the choices become nearly overwhelming. That does not even take into account the continuing interest in injection lipolysis/mesotherapy. So how is the average practicing cosmetic surgeon to decide what they should use (buy) for their practice?
The purpose of this editorial is NOT to promote any of these devices. But I could not easily find a source that compared outcomes, cost, durability, efficacy, or
The American Journal of Cosmetic Surgery Vol. 26, No. 2, 2009 safety among these choices. On a simple basis, one might just ask a trusted colleague, what are you using, and do you like it? But this is not science. Or one could simply try and contact the companies (just look through the ads in your journal(s) and see who answers your inquiry most promptly. Or, you might check out the internet and see what companies are providing the most advertising for their customers. Again, this doesn't answer the fundamental question, which device most fulfills the criteria of our 4 questions above?
The answer may not be discoverable in the literature today, but the answers do exist. We should be able to generate sufficient data from among our members. How to do this becomes the next question. One method would be using the Wiki model of collective intelligence. Wiki postulates that open, collaborative data generation can create an accurate information resource. The current Wikipedia model generates secondary source information. But the model can be expanded to primary intelligence collection. Questions like who uses what? or what is the individual case cost? or what are the outcomes? could be answered by the creation of the proper data input center. This is described as "a potentially efficient new means for scientific/technical communication/education/collaboration."? This is a new aspect of the Wiki phenomenon, and should be something that we in the AACS and The American Journal of Cosmetic Surgery explore in coming months.
Another technique would be to use a survey methodology. Surveys using internet based tools can generate date either through email or web-based questionnaires. There are a number of commercial as well as free instruments that can be uses, like Survey-Monkey, or Zoomerang which I have answered in email based surveys recently looking at rhinoplasty, breast augmentation techniques, and even child bearing among women surgeons. Using a professional researcher to help design such studies is helpful, but there are web-based resources that can provide guidance for these as well. 8 Collective intelligence can work in other ways, too. Groups exist that pool cases for analysis and discussion. For example, Dr. Michael Higgs, an Australian cosmetic surgeon has moderated a discussion group for difficult breast implant cases, and has amassed 88 unsatisfactory results, with attendant commentary from multiple participants recommending corrective strategies. This group, called the International Breast Consultative Group includes 33 participants who come from around the world and represent all specialties doing this kind of surgery. The case presentations are followed by reports on which strategy was used, and the result. The accumulated cases are being written up and will be published soon in the Australasian Journal of Cosmetic Surgery. I have followed his group's cases and discussions for about a year. The cases are challenging and the discussion as detailed as you could wish and should provide an impressive primer on managing the unsatisfactory result.
The challenge then, is to begin the process of correlating our individual experiences into a useful data base. With the proliferation of technology, we have an obligation to evaluate it critically, and carefully, in a timely fashion. Failure to do so results in physicians being fooled, patients being disappointed, and outcomes that are less than optimal. An excellent example of that is the recent study by Dr Rima Abraham on outcomes with Contour Thread." The thread, approved by the FDA in 2005 rapidly became a popular procedure, until production suddenly ceased. This long-term outcomes case review indicates a high complication rate, and poor cosmetic result when followed beyond one month if the thread lift is done as a stand alone procedure. Yet, an internet search for the thread yields page after page of advertisements for the procedure. The manufacture no longer produces the product, something you won't see in a cursory search. I suspect that a member survey, done a year or two ago would have identified the same result.
Our members/readers have the answers to many unanswered questions. It will be our job to extract, 61 collect, interpret, and present this information using new methods, new research tools, and new strategies.
